content: <?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
    <headerData>
      <submissionType>144</submissionType>
      <filerInfo>
        <filer>
          <filerCredentials>
            <cik>0001840315</cik>
            <ccc>XXXXXXXX</ccc>
          </filerCredentials>
        </filer>
        <liveTestFlag>LIVE</liveTestFlag>
  
  
  
      </filerInfo>
    </headerData>
    <formData>
      <issuerInfo>
        <issuerCik>0001314102</issuerCik>
        <issuerName>EYEPOINT PHARMACEUTICALS, INC.</issuerName>
        <secFileNumber>000-51122</secFileNumber>
        <issuerAddress>
          <com:street1>480 PLEASANT STREET</com:street1>
          <com:street2>SUITE B300</com:street2>
          <com:city>WATERTOWN</com:city>
          <com:stateOrCountry>MA</com:stateOrCountry>
          <com:zipCode>02472</com:zipCode>
        </issuerAddress>
        <issuerContactPhone>6179265000</issuerContactPhone>
        <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Ocumension Therapeutics</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
        <relationshipsToIssuer>
          <relationshipToIssuer>Director</relationshipToIssuer>
        </relationshipsToIssuer>
      </issuerInfo>
      <securitiesInformation>
        <securitiesClassTitle>Common Stock</securitiesClassTitle>
        <brokerOrMarketmakerDetails>
          <name>Tiger Brokers (Singappre) Pte. Ltd.</name>
          <address>
            <com:street1>1 Raffles Place, #35-61, One Raffles</com:street1>
            <com:street2>Place Tower 2</com:street2>
            <com:city>Singapore</com:city>
            <com:stateOrCountry>U0</com:stateOrCountry>
            <com:zipCode>048616</com:zipCode>
          </address>
        </brokerOrMarketmakerDetails>
        <noOfUnitsSold>3010722</noOfUnitsSold>
        <aggregateMarketValue>17853581.46</aggregateMarketValue>
        <noOfUnitsOutstanding>34301926</noOfUnitsOutstanding>
        <approxSaleDate>05/26/2023</approxSaleDate>
        <securitiesExchangeName>NASDAQ</securitiesExchangeName>
      </securitiesInformation>
      <securitiesToBeSold>
        <securitiesClassTitle>Common Stock</securitiesClassTitle>
        <acquiredDate>12/31/2020</acquiredDate>
        <natureOfAcquisitionTransaction>through a private placement from the issuer of the securities</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>EYEPOINT PHARMACEUTICALS, INC.</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>3010722</amountOfSecuritiesAcquired>
        <paymentDate>12/31/2020</paymentDate>
        <natureOfPayment>good funds</natureOfPayment>
      </securitiesToBeSold>
      <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
      <noticeSignature>
        <noticeDate>05/26/2023</noticeDate>
        <signature>YE LIU</signature>
      </noticeSignature>
    </formData>
  </edgarSubmission>
metadata_documents: [{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 2928}]
text: 144
  0001840315
  XXXXXXXX
  LIVE
  0001314102
  EYEPOINT PHARMACEUTICALS, INC.
  000-51122
  480 PLEASANT STREET
  SUITE B300
  WATERTOWN
  MA
  02472
  6179265000
  Ocumension Therapeutics
  Director
  Common Stock
  Tiger Brokers (Singappre) Pte. Ltd.
  1 Raffles Place, #35-61, One Raffles
  Place Tower 2
  Singapore
  U0
  048616
  3010722
  17853581.46
  34301926
  05/26/2023
  NASDAQ
  Common Stock
  12/31/2020
  through a private placement from the issuer of the securities
  EYEPOINT PHARMACEUTICALS, INC.
  N
  3010722
  12/31/2020
  good funds
  Y
  05/26/2023
  YE LIU